<?xml version="1.0" encoding="UTF-8"?>
<p class="p">A recent review of 17 RCT confirmed that the continuative administration of n-3 LCPUFAs doses &gt;1 g for three months has a beneficial effect also in metabolic syndrome patients, determining a reduction in triglycerides from 7â€“25% [
 <xref rid="B29-ijms-20-02118" ref-type="bibr" class="xref">29</xref>].
</p>
